BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27351431)

  • 21. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sorafenib inhibits 5-fluorouracil-resistant gastric cancer cell growth.
    Kim HM; Kim SA; Park SB; Cho JH; Song SY
    Scand J Gastroenterol; 2017 May; 52(5):577-584. PubMed ID: 28110575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-cancer activity of anti-p185HER-2 ricin A chain immunotoxin on gastric cancer cells.
    Zhou XX; Ji F; Zhao JL; Cheng LF; Xu CF
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1266-75. PubMed ID: 20594254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study.
    Ohtsu A; Shah MA; Van Cutsem E; Rha SY; Sawaki A; Park SR; Lim HY; Yamada Y; Wu J; Langer B; Starnawski M; Kang YK
    J Clin Oncol; 2011 Oct; 29(30):3968-76. PubMed ID: 21844504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells.
    Lian G; Li L; Shi Y; Jing C; Liu J; Guo X; Zhang Q; Dai T; Ye F; Wang Y; Chen M
    Int J Oncol; 2018 Mar; 52(3):804-814. PubMed ID: 29393385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human leptin induces growth inhibition and apoptosis in human gastric cancer MGC-803 cells.
    Wu N; Wang Y; Wang S; Chen Y; Yan J
    Clin Exp Med; 2013 Nov; 13(4):305-14. PubMed ID: 23001141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [DS2, a newly synthetic ent-kaurane diterpenoid analog, inhibits proliferation and migration of human gastric cancer cell].
    Zhu YL; Wang AF; Fan XX; Zhao NM; Ma YC
    Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):493-498. PubMed ID: 30060356
    [No Abstract]   [Full Text] [Related]  

  • 29. Curcumol inhibits the proliferation of gastric adenocarcinoma MGC-803 cells via downregulation of IDH1.
    Zang S; Tang Q; Dong F; Liu H; Li L; Guo F; Pan X; Lin H; Zeng W; Cai Z; Zhong Q; Zang N; Zang L
    Oncol Rep; 2017 Dec; 38(6):3583-3591. PubMed ID: 29039582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis induced by 5-fluorouracil, cisplatin and paclitaxel are associated with p53 gene status in gastric cancer cell lines.
    Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
    Int J Oncol; 2005 Jun; 26(6):1563-7. PubMed ID: 15870870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of proHB-EGF carboxy-terminal fragment nuclear translocation: a new molecular target therapy for gastric cancer.
    Shimura T; Kataoka H; Ogasawara N; Kubota E; Sasaki M; Tanida S; Joh T
    Clin Cancer Res; 2008 Jun; 14(12):3956-65. PubMed ID: 18559618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dual induction of apoptosis and autophagy by SZC014, a synthetic oleanolic acid derivative, in gastric cancer cells via NF-κB pathway.
    Rui LX; Shu SY; Jun WJ; Mo CZ; Wu SZ; Min LS; Yuan L; Yong PJ; Cheng SZ; Sheng WS; Yao TZ
    Tumour Biol; 2016 Apr; 37(4):5133-44. PubMed ID: 26547583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of combination of eicosapentaenoic acid and epirubicin on human gastric carcinoma cell strain MGC-803].
    Guo WD; Yu JC; Liu YQ; Kang WM; Peng WZ; Gu B; Dong JH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Jun; 29(3):353-8. PubMed ID: 17633461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of CD40 inhibits Fas- or chemotherapy-mediated apoptosis and increases cell motility in human gastric carcinoma cells.
    Yamaguchi H; Tanaka F; Sadanaga N; Ohta M; Inoue H; Mori M
    Int J Oncol; 2003 Dec; 23(6):1697-702. PubMed ID: 14612943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non--Small-Cell Lung Cancer Cells.
    Liu JT; Li WC; Gao S; Wang F; Li XQ; Yu HQ; Fan LL; Wei W; Wang H; Sun GP
    Clin Lung Cancer; 2015 Sep; 16(5):e55-66. PubMed ID: 25979647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [18F]2-fluoro-2-deoxy-D-glucose incorporation by AGS gastric adenocarcinoma cells in vitro during response to epirubicin, cisplatin and 5-fluorouracil.
    Suttie SA; Park KG; Smith TA
    Br J Cancer; 2007 Oct; 97(7):902-9. PubMed ID: 17848947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An in vitro study on the effects of the combination of salinomycin with cisplatin on human gastric cancer cells.
    Zhang Z; Zhao J; Pang Q; Wang A; Chen M; Wei X
    Mol Med Rep; 2017 Aug; 16(2):1031-1038. PubMed ID: 28627601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include: antiproliferative effects, induction of apoptosis and cell cycle deregulation.
    Yoshimizu N; Otani Y; Saikawa Y; Kubota T; Yoshida M; Furukawa T; Kumai K; Kameyama K; Fujii M; Yano M; Sato T; Ito A; Kitajima M
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():95-101. PubMed ID: 15298613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tyrosine kinase receptor inhibitor-targeted combined chemotherapy for metastatic bladder cancer.
    Wu CL; Ping SY; Yu CP; Yu DS
    Kaohsiung J Med Sci; 2012 Apr; 28(4):194-203. PubMed ID: 22453067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor effects of seleno-β-lactoglobulin (Se-β-Lg) against human gastric cancer MGC-803 cells.
    Yu J; Dong X; Wang L; Ji H; Liu A
    Eur J Pharmacol; 2018 Aug; 833():109-115. PubMed ID: 29859147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.